Amarantus Appoints Brian E. Harvey, MD PhD to Stra
Post# of 30027
Posted On: 03/06/2016 8:03:42 PM
Amarantus Appoints Brian E. Harvey, MD PhD to Strategic Advisory Board
Prior to his time at Pfizer, Dr. Harvey served as Vice President of Regulatory Policy at Sanofi , where he was the Liaison with U.S. Food and Drug Administration (FDA), served on the International Biologics and Biotechnology Taskforce and Biologics Key Issues Team, was on the Biotechnology Industry Organization (BIO) Regulatory Affairs Committee (RAC). He was the Signatory authority for Sanofi written comments to the FDA docket and was a Member of the Sanofi Policy Development Committee.
http://ir.amarantus.com/press-releases/detail...-strategic
Prior to his time at Pfizer, Dr. Harvey served as Vice President of Regulatory Policy at Sanofi , where he was the Liaison with U.S. Food and Drug Administration (FDA), served on the International Biologics and Biotechnology Taskforce and Biologics Key Issues Team, was on the Biotechnology Industry Organization (BIO) Regulatory Affairs Committee (RAC). He was the Signatory authority for Sanofi written comments to the FDA docket and was a Member of the Sanofi Policy Development Committee.
http://ir.amarantus.com/press-releases/detail...-strategic
(8)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼